This is qualitative study, based on patient-lived experiences to enable us to investigate the effects a delayed FM diagnosis has on patients' wellbeing. The findings will be analysed to identify its main effects and to understand how and why it effects patients' wellbeing.
Inclusion Criteria: Clinically diagnosed with Fibromyalgia by a healthcare professional (E.g: GP, Rheumatologist, Neurologist or Mental Health Professional), have experienced delays of 1 year or more before being officially diagnosed, you must be above the age of 18.
If you are interested in this research study, please email Jessica Coggins at [email protected]
or click here to fill in the survey: https://t.co/xLLfp1Ai1e
If you have any queries, then please contact Jessica.
If you are interested in this research study please
email Grace Lawrence at:- : [email protected]
or
click this link to fill out form: https://t.co/q5rGs3fyqa
@ksluka0101 We desperately need new drugs that offer different approaches. (and yes, there are some potential candidates) But, more meds that widen the amount of people able to get improvements in quality of life are also needed.
Des
Tonmya – First New Fibromyalgia Drug in 16 Years, But Questions Remain.
Approved by the FDA in the US. No information on any application within the UK/EU.
Des
https://t.co/bgbrdV4G6Q